首页> 外文期刊>Urology >Clinical pathway after robotic nephroureterectomy: Omission of pelvic drain with next-day catheter removal and discharge
【24h】

Clinical pathway after robotic nephroureterectomy: Omission of pelvic drain with next-day catheter removal and discharge

机译:机器人肾结直肠切除术后的临床途径:骨盆引流漏诊,第二天取下导管

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To determine the feasibility of applying a postoperative clinical pathway after robotic nephroureterectomy (RNU) targeting safe omission of a pelvic drain and removal of the bladder catheter on the day after surgery with hospital discharge on postoperative day 1 (POD#1). Methods We reviewed a prospectively collected database of all RNUs performed by a single surgeon (R.A.) since institution of our clinical pathway in 2008 that includes pelvic drain omission, bladder catheter removal the morning after surgery, and discharge on POD#1. Patient demographics, and perioperative and postoperative outcomes were evaluated. Ability to adhere to the pathway and achieving the described parameters and whether any resulting complications occurred were determined. Results RNU was performed in 29 patients with mean age and body mass index of 69 years (50-90 years) and 30 kg/m2 (19-41 kg/m 2), respectively. No patient required a pelvic drain, and 2 were discharged with a catheter. All but 2 patients (93%) were discharged on POD#1. Overall, successful pathway application was achieved in 26 of 29 patients (90%) including no drain, catheter removal on the morning after surgery, and discharge on POD#1. No patient developed urine leak or other complications related to early catheter removal. Conclusion Our clinical pathway after RNU allows safe omission of a pelvic drain with early discontinuation of the bladder catheter and discharge on the POD#1 in most patients. To our knowledge, similar pathways have not been previously achieved with nephroureterectomy by any approach, but should be considered by surgeons treating urothelial carcinoma of the upper urinary tract.
机译:目的确定机器人肾切除术(RNU)在术后第1天出院(POD#1)后出院后第二天安全盆腔引流和膀胱导尿管切除的术后临床路径的可行性。方法我们回顾性收集了自2008年实施临床路径以来由一名外科医生(R.A.)进行的所有RNU的数据库,该路径包括盆腔漏液,术后第二天早上取出膀胱导管以及POD#1出院。评估患者的人口统计资料以及围手术期和术后结果。确定坚持该途径并达到所述参数的能力以及是否发生任何导致的并发症。结果29例患者接受了RNU治疗,平均年龄和体重指数分别为69岁(50-90岁)和30 kg / m2(19-41 kg / m 2)。没有患者需要盆腔引流,并且有2名患者通过导管出院。除2例患者外(93%)所有患者均通过POD#1出院。总体而言,在29例患者中有26例(90%)获得了成功的通路应用,包括无引流,术后第二天早上拔除导管以及POD#1出院。没有患者出现尿液泄漏或其他与早期拔除导管相关的并发症。结论在大多数患者中,RNU术后的临床途径可安全撤除骨盆引流,并尽早停用膀胱导管并排出POD#1。据我们所知,以前没有通过任何方法通过肾结直肠切除术实现类似的途径,但是治疗上尿路尿路上皮癌的外科医生应考虑采用类似的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号